IQVIA (IQV) — insider trading
Health Care · NYSE
IQVIA (IQV) has 32 reported SEC Form 4 insider transactions in our data, including 9 open-market sales among the most recent 32 (latest 2026-09-02).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | Berkshire James G. | Officer (See Remarks) | Option exercise / conversion (derivative) | 5,381 | $131.82 | $709.3K | Form 4 |
| 2026-09-02 | Berkshire James G. | Officer (See Remarks) | Disposition to the issuer | 2,713 | $261.54 | $709.6K | Form 4 |
| 2026-09-02 | Berkshire James G. | Officer (See Remarks) | Open-market sale | 2,668 | $261.33 | $697.2K | Form 4 |
| 2026-09-02 | Berkshire James G. | Officer (See Remarks) | Option exercise / conversion | 5,381 | $131.82 | $709.3K | Form 4 |
| 2026-08-03 | STAUB W RICHARD | Officer (See Remarks) | Open-market sale | 5,500 | $232.68 | $1.28M | Form 4 |
| 2026-07-31 | Patel Bhavik | Officer (See Remarks) | Open-market sale | 1,855 | $235.27 | $436.4K | Form 4 |
| 2026-07-29 | BOUSBIB ARI | Director, Officer (See Remarks) | Option exercise / conversion (derivative) | 156,206 | $78.21 | $12.22M | Form 4 |
| 2026-07-29 | BOUSBIB ARI | Director, Officer (See Remarks) | Disposition to the issuer | 2,069 | $247.00 | $511.0K | Form 4 |
| 2026-07-29 | BOUSBIB ARI | Director, Officer (See Remarks) | Disposition to the issuer | 47,858 | $244.60 | $11.71M | Form 4 |
| 2026-07-29 | BOUSBIB ARI | Director, Officer (See Remarks) | Open-market sale | 53,191 | $244.78 | $13.02M | Form 4 |
| 2026-07-29 | BOUSBIB ARI | Director, Officer (See Remarks) | Open-market sale | 44,039 | $246.08 | $10.84M | Form 4 |
| 2026-07-29 | BOUSBIB ARI | Director, Officer (See Remarks) | Open-market sale | 4,584 | $246.85 | $1.13M | Form 4 |
| 2026-07-29 | BOUSBIB ARI | Director, Officer (See Remarks) | Open-market sale | 4,465 | $247.10 | $1.10M | Form 4 |
| 2026-07-29 | BOUSBIB ARI | Director, Officer (See Remarks) | Option exercise / conversion | 156,206 | $78.21 | $12.22M | Form 4 |
| 2026-07-29 | Cherofsky Keriann | Officer (See Remarks) | Open-market sale | 558 | $245.21 | $136.8K | Form 4 |
| 2026-07-29 | Sherbet Eric | Officer (See Remarks) | Open-market sale | 5,000 | $249.16 | $1.25M | Form 4 |
| 2026-07-14 | DANHAKL JOHN G | Director | Grant / award / vesting (derivative) | 160 | $207.83 | $33.3K | Form 4 |
| 2026-07-14 | Fasano Jim | Director | Grant / award / vesting (derivative) | 195 | $207.83 | $40.5K | Form 4 |
| 2026-07-14 | GOGGINS COLLEEN A | Director | Grant / award / vesting (derivative) | 183 | $207.83 | $38.0K | Form 4 |
| 2026-07-14 | Wims Morris Leslie | Director | Grant / award / vesting (derivative) | 148 | $207.83 | $30.8K | Form 4 |
| 2026-05-07 | DANHAKL JOHN G | Director | Grant / award / vesting (derivative) | 185 | $178.64 | $33.0K | Form 4 |
| 2026-05-07 | Fasano Jim | Director | Grant / award / vesting (derivative) | 228 | $178.64 | $40.7K | Form 4 |
| 2026-05-07 | GOGGINS COLLEEN A | Director | Grant / award / vesting (derivative) | 214 | $178.64 | $38.2K | Form 4 |
| 2026-05-07 | Wims Morris Leslie | Director | Grant / award / vesting (derivative) | 171 | $178.64 | $30.5K | Form 4 |
| 2026-04-23 | Burt Carol | Director | Grant / award / vesting | 1,571 | — | $0 | Form 4 |
| 2026-04-23 | DANHAKL JOHN G | Director | Grant / award / vesting | 1,571 | — | $0 | Form 4 |
| 2026-04-23 | Fasano Jim | Director | Grant / award / vesting (derivative) | 1,571 | $160.68 | $252.4K | Form 4 |
| 2026-04-23 | GOGGINS COLLEEN A | Director | Grant / award / vesting | 1,571 | — | $0 | Form 4 |
| 2026-04-23 | LEONARD JOHN M | Director | Grant / award / vesting | 1,571 | — | $0 | Form 4 |
| 2026-04-23 | Kaelin William G Jr | Director | Grant / award / vesting (derivative) | 1,571 | $160.68 | $252.4K | Form 4 |
| 2026-04-23 | Wims Morris Leslie | Director | Grant / award / vesting (derivative) | 1,571 | $160.68 | $252.4K | Form 4 |
| 2026-04-23 | Stamps Sheila A | Director | Grant / award / vesting (derivative) | 1,571 | $160.68 | $252.4K | Form 4 |
Ask the chat about IQV's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: IQVIA (IQV).
Last updated 2026-09-02 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.